Meta

Category: Healthia Consulting

It is not every day that you see a couple of titans of industry clash with one another. This is exactly what has been going on between CVS and Amazon though. Both have butted heads with one another as Amazon seeks to creep into CVS territory and marketshare while CVS tries to shore up their defenses against such invasion.

Healthcare information technology entrepreneur Drew Madden has been watching this all unfold very careful. He is trying to work out what the implications of these moves are going to be for all of the rest of us. The good news is that he largely sees this working out well for the consumer in the long run. He believes that it is entirely possible that both companies could find a good spot in the market and serve different customer needs.

Amazon is seeking to obtain licenses to sell pharmaceuticals over the Internet in a number of different states. Meanwhile, CVS has purchased the healthcare insurance giant Aetna. They hope to use this acquisition to have a stake in the healthcare process of a new patient from the point when they purchase insurance all the way up until they get the prescription filled (hopefully at CVS).

As another goodie for their customers, CVS is offering guaranteed next-day delivery at all of their MinuteClinic locations nationwide. That means that they can try to stay on par with one of the nicest features that Amazon has going for it. That being the fact that they can deliver so many items in just one day. CVS is trying to stay on level with that by making this own offerings via the MinuteClinic. It does seem to appeal to at least some of their customers in a lot of ways.

We are still in the early stages of this particular corporate conflict. There is no telling how it will all play out in the end. For now though, Drew Madden believes that we have all the reasons in the world to remain hopeful and optimistic that things are going to go just fine. He has followed these types of stories before, so we should trust his judgement on this one too.